CRON Q1 2025 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$32M+27.6% YoY

Gross Profit

$14M42.6% margin

Operating Income

-$4M-12.6% margin

Net Income

$6M19.0% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+6.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$39M

Stockholders' Equity

$1.1B

Cash & Equivalents

$798M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$25M	+27.6%
Gross Profit	$14M	$4M	+206.4%
Operating Income	-$4M	-$16M	+74.5%
Net Income	$6M	-$2M	+373.2%

Revenue Segments

Cannabis Flower

$23M72%

Cannabis Extracts

$9M27%

Product and Service, Other

$310,0001%

Geographic Segments

CANADA

$20M62%

ISRAEL

$9M29%

Other Countries

$3M9%